Compositions and methods for the therapy and diagnosis of lung cancer

An isolated polynucleotide comprising a sequence selected from the group consisting of:

• (a) a sequence provided in SEQ ID NOs:
• 1931, 1938, 1941 and 1974-2002;
• (b) complement of the sequence provided in SEQ ID NOs:
• 1931, 1938, 1941 and 1974-2002;
• (c) sequences consisting of at least 20 contiguous residues of a sequence provided in SEQ ID NOs:
• 1931, 1938, 1941 and 1974-2002;
• (d) sequences that hybridize to a sequence provided in SEQ ID NOs:
• 1931, 1938, 1941 and 1974-2002, under highly stringent conditions;
• (e) sequences having at least 75% identity to a sequence of SEQ ID NOs:
• 1931, 1938, 1941 and 1974-2002;
• (f) sequences having at least 90% identity to a sequence of SEQ ID NOs:
• 1931, 1938, 1941 and 1974-2002;
• and
• (g) degenerate variants of a sequence provided in SEQ ID NOs:
• 1931, 1938, 1941 and 1974-2002: